Frequently Asked Questions
The market is segmented based on , By Types (Exertional Heat Stroke, Non-Exertional Heat Stroke), Mechanism of Action (Antihistamines, Diuretics, Sedatives, Stimulants, Anticonvulsants, Vasoconstrictors, Others), Drugs (Dantrolene, Midazolam, Clonidine, Meperidine, Others), Diagnosis (Rectal Temperature, Blood Test, Urine Test, Muscle Function Test, Others), Treatment (Medication, Cold Therapy, Supportive Care), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End Users (Hospitals, Homecare, Specialty Clinics, Others) – Industry Trends and Forecast to 2030.
.
The Global Heatstroke Treatment Market size was valued at USD 10387.00 USD Million in 2022.
The Global Heatstroke Treatment Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include Novartis, AstraZeneca, Pfizer, Sanofi, Johnson & Johnson, AbbVie, Allergan, Merck & Co., Amgen, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Takeda Pharmaceutical Company, Abbott, Mankind Pharma, Eagle Pharmaceuticals, DAIICHI SANKYO COMPANY, Patanjali Ayurved, Otsuka Holdings, Eli Lilly and Company, Medisim.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
